# V5 R2.22 GPT-5.6 Blinded Review Result

Date completed: 2026-07-28  
Scope: 32 owner-approved R2.20 Development-confirmation questions

## Outcome

The isolated-context GPT-5.6 reviewer completed 32/32 items with
0 schema errors. This is supplemental AI triangulation, not an
independent human, clinical, or expert review.

| Measure | Overall |
|---|---:|
| Exact evidence-contract agreement | 59.4% |
| Role-compatible evidence-contract agreement | 65.6% |
| Current-candidate agreement | 87.5% |
| Paired-candidate agreement | 68.8% |
| Fully answerable | 96.9% |
| Mean confidence | 4.84 / 5 |

## By stratum

| Stratum | n | Exact contract | Role-compatible contract | Current candidate | Paired candidate |
|---|---:|---:|---:|---:|---:|
| conditional_merge | 10 | 30.0% | 30.0% | 90.0% | 40.0% |
| compatible_history | 10 | 40.0% | 60.0% | 70.0% | 90.0% |
| current_only | 6 | 100.0% | 100.0% | 100.0% | 100.0% |
| hard_negative_current | 6 | 100.0% | 100.0% | 100.0% | 50.0% |

## Disclosure boundary

The reviewer saw only a checksum-frozen, A/B-order-randomized packet and fixed
rubric. It did not see original IDs, strata, gold roles, retrieval rankings, or
R2.20/R2.21 outcomes. Because the reviewer is an AI system and may share model
family or training-data biases with annotation tooling, the result supports
robustness triangulation only and does not replace blinded human or clinical
validation.

## Disagreements

- `r2.20-confirm-01` (conditional_merge): reviewer=b_only, expected=both_required; current=true; paired=false. B directly reports systolic and diastolic effects across baseline potassium-intake groups and contrasts normotensive with hypertensive participants; A adds overlapping subgroup detail.
- `r2.20-confirm-02` (conditional_merge): reviewer=b_only, expected=both_required; current=false; paired=true. B supplies effect estimates across both baseline potassium and sodium exposure levels, while A adds interpretation of the sodium findings but is not necessary.
- `r2.20-confirm-03` (conditional_merge): reviewer=b_only, expected=both_required; current=true; paired=false. B states the trial findings and distinguishes comparisons with sugars, placebo or water, and explicit sugar replacement, which directly supplies the limiting comparison context.
- `r2.20-confirm-04` (conditional_merge): reviewer=a_only, expected=both_required; current=true; paired=false. A identifies preterm birth, inconsistent offspring-weight findings, other offspring outcomes, gestational diabetes, and the corresponding low or very-low certainty ratings.
- `r2.20-confirm-07` (conditional_merge): reviewer=a_only, expected=both_required; current=true; paired=false. A defines physical activity as any energy-requiring skeletal-muscle movement and gives a concrete multicomponent programme combining aerobic, strength, and balance activities.
- `r2.20-confirm-09` (conditional_merge): reviewer=a_only, expected=both_required; current=true; paired=false. A directly explains the conditional recommendation, the risk of replacing fat with free sugars, the need for carbohydrate-quality guidance, and outcome-specific certainty.
- `r2.20-confirm-10` (conditional_merge): reviewer=b_only, expected=both_required; current=true; paired=false. B directly combines nutritional-adequacy safeguards for different populations with the stated GINA-based monitoring approach; A offers only generic policy monitoring context.
- `r2.20-confirm-11` (compatible_history): reviewer=a_only, expected=both_required; current=false; paired=true. A identifies food, especially fruits and vegetables, as the primary source and enumerates renal, cardiac, metabolic, medication-related, older-adult, and infant risk groups.
- `r2.20-confirm-14` (compatible_history): reviewer=a_only, expected=both_required; current=false; paired=true. A directly contrasts null RCT findings with positive cohort associations and explains reverse causation and baseline differences as possible, but inconsistent, explanations.
- `r2.20-confirm-16` (compatible_history): reviewer=a_only, expected=both_required; current=false; paired=true. A enumerates critical and important outcomes and specifies dose-response, sedentary-behaviour type or domain, interruption characteristics, and physical activity as effect modifiers.
- `r2.20-confirm-17` (compatible_history): reviewer=a_only, expected=both_required; current=true; paired=false. A gives limited safety-relevant context on absent pregnancy studies, potassium-containing formulations, composition variability, and cautious subgroup interpretation, but does not report the main adverse-event evidence; B concerns sodium reduction rather than substitute safety.
- `r2.20-confirm-28` (hard_negative_current): reviewer=a_only, expected=a_only; current=true; paired=false. A describes exclusions, baseline-risk restrictions, lag analyses, varied attenuation or strengthening, and the persistence of many associations after adjustment and sensitivity testing.
- `r2.20-confirm-30` (hard_negative_current): reviewer=b_only, expected=b_only; current=true; paired=false. B explicitly states the evidence-informed objective and intended use by policy-makers and other stakeholders to reduce sodium, hypertension, and related NCD risk through policies and programmes.
- `r2.20-confirm-32` (hard_negative_current): reviewer=a_only, expected=a_only; current=true; paired=false. A provides the recent global adult and child burden, deaths attributable to high BMI and NCDs, rapid LMIC growth, double malnutrition burden, and dietary transition motivating the guidance.
